Shares of DexCom Inc. DXCM slipped 1.53% to $60.69 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 1.57% to 4,982.77 and Dow ...

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Dexcom (DXCM – Research Report), with a price ...

O Shaughnessy Asset Management LLC raised its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 16.9% during the fourth quarter, according to its most recent filing with the SEC. The ...

DexCom (NasdaqGS:DXCM) experienced an 12% decline over the past week, during which the company transitioned its audit from Ernst & Young to Deloitte & Touche, and appointed Jon Coleman as Chief ...

In mid-March here, I (Tom Yeung) wrote about three stocks to sell on an escalating trade war. President Donald Trump was ratcheting his tariff rhetoric, so we highlighted three import-reliant firms to ...

Shares of DexCom Inc. DXCM shed 9.30% to $61.80 Thursday, on what proved to be an all-around grim trading session for the ...

(Reuters) -Megacap U.S. tech companies including Apple (NASDAQ: AAPL) and retail giants Walmart (NYSE: WMT) and Nike (NYSE: ...

Despite intensive medtech industry lobbying to secure a carve-out from the Trump administration’s expansive tariffs on all ...

Sands Capital, an investment management company, released its “Sands Capital Select Growth Fund” Q4 2024 investor letter. A ...

DexCom's recent licensing deal with Nanowear is likely to reinforce the broader potential of CGMs in continuous metabolic health monitoring.

For the quarter, the Baird Mid Cap Growth portfolio produced a negative return of -1.3%, net of fees, trailing the Russell ...